
Intellia Therapeutics, Inc.
USD16.06
-0.55 (-3.31%)
CEO
John Leonard
IPO Date
2016-05-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.57
Prev. Close
$16.61
Day Low
$16.00
Day High
$16.73
52W Low
$7.95
52W High
$28.25
Market Cap
$1.80B
Volume
0.41M
| 15 Jun 2026 |
| Wedbush |
| Neutral |
| Neutral |
| maintain |
| 13 May 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 13 May 2026 | Bernstein | Market Perform | Market Perform | maintain |
| 12 May 2026 | Canaccord Genuity | Buy | Buy | maintain |
| 12 May 2026 | Wedbush | Neutral | Neutral | maintain |
| 28 Apr 2026 | Goldman Sachs | Sell | Sell | maintain |
| 28 Apr 2026 | Citizens | Market Outperform | Market Outperform | maintain |